We evaluated the accuracy of delivery of one type of infusion pump at three nominal flow rates under two environmental pressures (measured in atmospheres absolute, ATA), one of which is used for hyperbaric oxygenation. Overall, we observed significant differences between the two different pressures (1 ATA and 2 ATA). Changes in the rate of delivery of between about -4% and +2% were observed over the time course of hyperbaric oxygenation, and the inter-group difference was significant in the phases in which pressure was changing. The effect produced by 2 ATA was statistically significant but small, and its influence is likely to be negligible during practical hyperbaric oxygenation therapy. Thus, it would seem that this type of pump would deliver reliably at the nominal rate during hyperbaric oxygenation at these levels.
Hyperbaric oxygenation (HBO) is employed in the treatment of many conditions, including critically ill patients with severe infections. It may be necessary to give drugs continuously under strict management during HBO. Many different pumps are used and while one type has been reported to exhibit flow instability, others work well [1] [2] [3] [4] . However, the performance under hyperbaric conditions of Terumo products, which are used worldwide, has not been evaluated. Consequently, we decided to investigate the effect of such conditions on the actual rate of infusion delivered by one type of Terumo infusion pump.
METHODS
We tested two different examples of one type of infusion pump (STC-3121; Terumo Inst., Tokyo, Japan). We evaluated their accuracy at two different environmental pressures (1 atmosphere absolute (ATA) and 2 ATA). A 50 ml syringe (Terumo syringe, Terumo Inst.) was filled with water and fitted to the pump, and the nominal infusion rate was set at 10 ml/h, 20 ml/h, or 30 ml/h. HBO was performed using a multiplace chamber type of machine for HBO therapy (Nakamura Inst., Tokyo, Japan). To simulate the conditions experienced during HBO, we increased the pressure on the pumps to 2 ATA using a pattern of pressure changes commonly used in HBO therapy. The pressure was first slowly raised to 2 ATA over a period of 10 minutes (min), then maintained at 2 ATA for 60 min, and finally slowly decreased to 1 ATA over the next 15 min with a plateau at 0.3 ATA for 5 min (total time 85 min, Figure 1 ). As a control, we also evaluated the accuracy of the same pumps at 1 ATA over 85 min. To simulate clinical use, the pump was started 4 to 43 min (pre-measurement period) before the 85 min measurement period. The pre-measurement period varied because we performed this experiment during the course of our daily treatment of patients and the start time for each HBO treatment could not be predicted exactly. Moreover, the measurement device had a limited capacity, and the largest flow rate (30 ml/hr) necessitated shorter pre-measurement periods.
Measurements and Calculation
We performed the volume measurements using glass volumetric measuring cylinders made by Yamaguchi Riken Inst. (Fukuoka, Japan). The output from the syringe was discharged into the cylinder through a side-tube near the base. For measurements at a nominal pump rate of 10 ml/h, we used a small cylinder inscribed with a scale with 0.25 ml divisions, while for the faster pump rates (20 or 30 ml/h) we used a larger cylinder with 0.5 ml divisions. Volume measurements using these devices were carried out at four time-points: T1, at 10 min after measurements started (T=0); T2, at 30 min after T1; T3, at 30 min after T2; T4, at 15 min after T3. Each volume was used to calculate the flow rate for the preceding time period (Tables 1 to 3) enabling us to observe the influence of ambient pressure.
Flow rates and percentage differences between groups (2 ATA/HBO and 1 ATA) were calculated as follows:
1. flow rate: =(volume at T aft-flow at T pre)/ nominal volume during the same time 2. Percentage difference in flow rate (for a given time period)=100 X (flow rate for HBO-flow rate for 1 ATA)/flow rate for 1 ATA where "T aft" represented the time-point at which the particular volume measurement was made; "T pre": the preceding time-point; "Volume aft": volume at "T aft" and "Volume pre": volume at "T pre".
The values given in the tables were obtained by averaging those obtained from the two individual machines (A and B).
All statistical calculations were performed using the STATCEL program (OMS, Japan) and Statview 5 for Apple Macintosh computers. Mean and standard deviation were determined for each set of data. Inter-and intra-group differences were analyzed by the Bonferroni Dunn test for multiple comparisons. Differences in the lengths of the pre-measurement periods were analyzed using an unpaired t-test. P values less than 0.05 were considered to be significant.
RESULTS

Pre-measurement Times
When the nominal rate was 10 ml/h, the premeasurement times were 22.9±8.4 min at 1 ATA and 26.1±5.3 min for HBO (P>0.05). At 20 ml/h, the corresponding times were 24.1±7.9 min at 1 ATA and 26.1±11.9 min for HBO (P>0.05). At 30 ml/h, the times were 7.0±1.3 min at 1 ATA and 11.3±4.9 min for HBO (P<0.05).
Flow rates and percentage differences in flow rate between two different environmental pressures (1 ATA vs 2 ATA) at three nominal infusion rates. a) Nominal rate 10 ml/h (Table 1)
In the repeated measures ANOVA, there was a significant difference between the groups in terms of flow rates. We also saw an interaction between the groups, which implies a different pattern of change of flow rate between the different circumstances. The inter-group difference was between -4.2% and +2.3%. In the intra-group multiple analysis, we saw a significant inter-group difference in the flow rate measured at T1. We also saw a significant intra-group difference within the HBO (2 ATA) group, but only at T1 vs T4 and T3 vs T4. b) Nominal rate 20 ml/h ( Table 2) There was no significant difference or interaction with time between the two groups. No intra-group differences were detected within either group. c) Nominal rate 30 ml/h ( Table 3) There was a significant difference between the two groups (repeated measures ANOVA). We also saw an interaction between the two groups, which implied a different pattern of change in flow rate. There was a significant intra-group difference between T1 and T4 at 2 ATA. An inter-group difference in flow rate was seen at T1 (multiple comparison test).
DISCUSSION
The study demonstrated significant differences and interactions within tests carried out at different external pressures. However, significant differences were seen only at some nominal flows. The differences and interactions were attributable to those phases in which pressure was changing dynamically during HBO. This suggests that it was the dynamic change in pressure that induced a change in flow rate. The main factor responsible for these pressure-related differences is not clear, but we speculate that the higher environmental pressure increases the resistance against which the pump works, thus causing a change in infusion rate. Over the 60 min period for which the pressure was constant, even at 2 ATA, the pumps gave accurate results at all three nominal rates. The intra-group differences that were seen were of the order of a few percent. Thus, in normal clinical use, this effect of environmental pressure would be small, leading to the conclusion that this pump is suitable for use under the conditions tested here. However, the act of changing the environmental pressure may become a more important influence on pump performance if pumps are exposed to more rapid changes in pressure or a higher final pressure. If so, it will be necessary to be particularly careful when increasing pressure over a given time to higher levels than those we employed.
In the present study, we found differences between the two groups at two infusion rates (10 and 30 ml/h nominal rate), but not at the other (20 ml/h). We are unsure whether this would be a consistent finding and as to the exact reason for this discrepancy. However, some explanation can be attempted. The measuring devices were different in terms of calibration, and the differences between group means were often smaller than one of these divisions. Possibly, differences Data are expressed as mean±SD. T1 to T4 refer to the time-points during a given collection period. There was a significant difference (P<0.0001, repeated measures ANOVA) and interaction (P<0.01) between groups. In the multiple analysis a significant difference between the two groups and intra-group differences within the HBO data were observed: # P<0.05, HBO-T1 vs 1 ATA-T1; *P<0.05, HBO-T1 vs HBO-T4; P<0.05, HBO-T3 vs HBO-T4. Data are expressed as mean±SD. T1 to T4 refer to the time-points during a given collection period. There were no significant differences between the two groups by repeated measures ANOVA (P=0.11), and no significant intra-group differences (P=0.30).. Data are expressed as mean±SD. T1 to T4 refer to the time-points during a given collection period. There was a significant difference (P<0.0001, repeated measures ANOVA) and interaction (P<0.01) between the two groups. There was a significant intra-group difference within the HBO data: # P<0.05, HBO-T1 vs 1 ATA-T1; *P<0.05, HBO-T1 vs HBO-T4.
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Anaesthesia and Intensive Care, Vol. 28, No. 1, February 2000 might have been exaggerated or diminished if devices with different calibrations had been used. Furthermore, the manufacturer states that pump flow is not in a strictly continuous pattern but in a wave-like pattern of short-duration fluctuations; and the frequency of these fluctuations will depend on the infusion rate selected. Exactly when a measurement was started and stopped in relation to the various phases of these waves might have led to small apparent differences in infusion rate. The combination of these two factors (calibration and the way flow is produced) may have influenced the results.
In the present study, the pre-measurement time was shorter at the nominal rate of 30 ml/h than at the other nominal rates. At 30 ml/h, the pre-measurement time was longer for HBO (mean, 11.3 min) than for 1 ATA (mean, 7.0 min), and the flow rate at T1 was significantly smaller for the former than for the latter. This inter-group difference in pre-measurement time might have had some influence on the flow data. However, we also found a significant difference between flow rates at T1 at a nominal 10 ml/h (when there was no significant difference between premeasurement times, and the pre-measurement times were much longer). This suggests that it was the higher pressure in HBO, rather than the difference in pre-measurement times, that caused the decrease in flow rate seen when HBO was applied at 30 ml/h.
In this study, the significant differences all occurred during phases in which pressure was changing dynamically during HBO. While we believe that the significant differences seen when an environmental pressure of 2 ATA was used reflected real differences induced by the pressure itself, differences detected between 2 ATA and 1 ATA were, in the main, quite small. Nearly all amounted to less than about ±4% (Tables 1-3 ). Over the time course normally used for HBO, these are unlikely to be an important influence on the patient's clinical course. For example, these pumps could be employed with confidence to deliver catecholamines in the management of the circulation.
This conclusion differs from one previous investigation 1 . However, that study tested pumps from another manufacturer (Atom Inst. Ltd, Japan), and it would not be surprising if different models varied in their ability to operate at different environmental pressures. In addition, that study used a different methodology. It is important to appreciate that any conclusion drawn about a particular type of pump only holds good for the conditions under which it was examined.
In conclusion, the performance of the type of Terumo infusion pump we tested was affected by hyperbaric conditions (at 2 ATA) at two out of three infusion rates. However, the discrepancies from the set rate were small (between about -4% and +3%). We therefore consider that such pumps could be used during HBO with confidence in their accuracy in delivering at the set rate. However, if higher ATA levels are to be used, the difference in performance produced by changing to a different environmental pressure might become important. Direct visual observation of the working of any infusion pump is important for fear that an error might occur and have a potentially deleterious effect on the patient.
